Wed, Jul 8, 2015
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

I2BF and RUSNANO Capital launch strategic resources Fund to invest in Russian nanotech market

Wednesday, July 18, 2012
Opalesque Industry update – Rusnano Capital (RNC), the Russian government-owned nanotechnology investment company, and international technology investment group I2BF Global Ventures have announced the launch of the I2BF-RNC Strategic Resources Fund to invest in later-stage nanotechnology companies. The seven-year fund launches with a $53m commitment from its LPs with a target fund size of $150m.

Its remit will be to invest in international nanotechnology that has applications of value within the Russian Federation, with a focus on the resource sector as well as water and agriculture.

“We are delighted to partner with Rusnano Capital on our first late-stage venture fund expanding on I2BF’s existing investment expertise,” says Ilya Golubovich, Managing Partner of I2BF Global Ventures (right). “It is important in a fast-maturing nanotech market that together we are now able to offer expansion capital to larger companies with proven technologies. The opportunities to roll out nanotech applications and also production facilities in Russia are widespread and we will be using our global footprint to channel the best technologies into this market.”

“Agriculture and water supply industries in Russia offer an immense source for growth,” says Irina Rapoport, CEO of Rusnano Capital. “We are planning to capitalize and develop those branches of the economy together with I2BF Global Ventures which has a unique combination of venture industry experience as well as a Russian edge.”

Nanotech applications are increasingly widespread in sectors as diverse as food and agriculture, consumer electronics, energy production and storage, and medicine. Nanoresearch firm Cientifica estimates that since 2000 governments have invested over $65bn in nanotech research. Russia has been a leading player since the creation of Rusnano in 2007. Compound global growth rates in the sector are expected to hit 18% between 2010 and 2013. Part of the attraction of nanotech is increasing the efficiency of materials and processes in an increasingly resource constrained world.

(press release)

I2BF Global Ventures is an international clean technology venture capital firm with a global investment mandate, based in New York. Established in 2005, I2BF manages over USD 200 million across four venture capital vehicles and has completed 19 investments since the first portfolio company investment in 2006. I2BF Global Ventures seeks out game-changing technologies, and to invest in the most innovative and competitive companies targeting sectors and technologies it believes can lead the path to a “Brighter Future”. In keeping with its worldwide investment focus, further to the team in New York, I2BF retains a team of technology and sector experts including renewable energy researchers in London, Moscow and Dubai, www.i2bf.com.

RUSNANO Capital is a subsidiary of OJSC RUSNANO and was established in 2010 for the purpose of fund management and corporate control of RUSNANO investment. Key goals assigned to RUSNANO Capital are innovative technology transfer to Russia and attracting foreign investment capital for co-investment in Russian nanotechnology projects. Total assets under management RUSNANO Capital are $ 1 billion, currently registered and started five investment funds focused on such industry sector’s as medicine and pharmaceutics, "green" technologies and alternative energy, developing new materials.

Bg

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Opalesque Exclusive: New systematic strategy managed alongside research firm outperforms S&P500[more]

    Benedicte Gravrand, Opalesque Geneva for New Managers: An emerging CTA manager explains how he runs his strategy, which is based on an index produced by a research firm. Peter Turk is head of

  2. Opalesque Exclusive: New systematic strategy embraces machine learning[more]

    Benedicte Gravrand, Opalesque Geneva for New Managers: The founder of a New York-based systematic trading firm, which offers a hybrid between alpha strategies and alternative feta at lower fees, describes his approa

  3. Larry Robbins' hedge fund Glenview buys 1m Tenet Healthcare shares[more]

    Komfie Manalo, Opalesque Asia: Glenview Capital Management said it bought an additional 979,482 shares at Tenet Healthcare Corp valued at $53.80 million, raising its stakes in the healthcare services company to 15.16%, reported

  4. Legal - Grayson’s hedge funds under scrutiny for possible ethics violations, Court rejects hedge fund’s motion to block merger of Samsung affiliates[more]

    Grayson’s hedge funds under scrutiny for possible ethics violations From Freebeacon.com: Rep. Alan Grayson is finding himself in hot water over managing hedge funds that bear his name, actions that are in possible violation of House ethics rules. Sitting members of Congress are prohibite

  5. Hedge funds decline in June as stocks tumble on Greek woes[more]

    From Bloomberg.com: Hedge funds posted losses across strategies last month as uncertainty over whether Greece will remain in the euro sent global stock markets tumbling. Winton Capital Management declined about 3.1 percent in June in its $12.1 billion Winton Futures Fund, leaving it down 1.9 percent

 

banner